A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
Clin Cancer Res
; 28(11): 2306-2312, 2022 06 01.
Article
in En
| MEDLINE
| ID: mdl-35349638
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leiomyosarcoma
/
Liposarcoma
Limits:
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article